Regulatory
PharmaVoice
The end of MAHA?; Inovio’s big FDA win
American voters turned their noses up at MAHA-aligned candidates this week; Inovio won a breakthrough nod for a DNA-based therapy.
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Regulatory
PharmaVoice
American voters turned their noses up at MAHA-aligned candidates this week; Inovio won a breakthrough nod for a DNA-based therapy.
Research P Pharmaceutical Executive
The termination ends a cardiometabolic RNA-editing partnership that was paused for 12 months, closing out a deal under which Korro earned no milestone payments.
Software S SecureBio
A SecureBio and RAND analysis of participant transcripts from the 2025 Active Site wet-lab uplift study finds that LLMs frequently gave incorrect advice, suggesting tacit knowledge was not the only barrier to novice uplift.
Agriculture
AgriBusiness Global
Revenue rises 6% as Coromandel navigates cost pressures, expands capacity, and strengthens its diversified agri-solutions portfolio. The post Coromandel Posts Revenue Growth Amid Margin Pressures, Advances Strategic Expansion appeared first on AgriBusiness Global.
Regulatory
BioSpace
After the FDA delayed a decision for Agios Pharmaceuticals’ sickle cell disease candidate, the biopharma is letting go of more than 35% of its R&D employees.
Funding B BioPharm International
Oxford spinout Alethio Therapeutics closed a $90 million Series A to take ATX-011, a monoclonal antibody against the G6B receptor, into Phase 1/2a studies in essential thrombocythemia. It is also developing a G6B-targeted ADC for myelofibrosis.
Manufacturing B BioProcess International
Countries signed up to the UN bioweapons treaty are drafting a compliance and verification protocol, with commercial facilities and process data potentially within its remit.
Industry
Labiotech
The name change from PCOS to PMOS hopes to reverse misdiagnoses rates and spread awareness about a complex endocrine disorder. The post Zooming out from ovaries: how has renaming PMOS changed lives? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthoriz…
Agriculture
CropLife
Ben Hushon, Certified Crop Advisor from The Mill, discusses dealing with growers who won’t make purchase decisions, strategizing for fertilizer sales, and how to get growers to use Smart Tech. The post CropLife Retail Week: Dealing with Grower Decision Paralysis, 2027 Fertilizer…
Industry P PLOS Biology
by Neha Gupta, Lei Zhang, Hiroki Akizawa, Maria G. Gervasi, Darya A. Tourzani, Pablo E. Visconti, Ana Romarowski, Mariano Buffone, Wei Cui, Rafael A. Fissore Fertilization-induced calcium (Ca2+) oscillations are essential for egg activation and embryonic development in mammals. T…
Industry
GEN
A priority shift is redefining expectations for contract development and manufacturing organizations (CDMOs). This article explains how CDMOs can efficiently move their glycosylation processes upstream using quality-by-design (QbD) methodologies. The post Why Glycosylation Contro…
Regulatory P Pharmaceutical Executive
Accelerated approval of subcutaneous Rybrevant Faspro (amivantamab) based on a 42% response rate in 102 patients; a phase 3 confirmatory trial is under way.
Funding B BioPharm International
T-Therapeutics closed an oversubscribed $133 million Series B backed by Eli Lilly, JJDC, and others. The funding will take its first T-cell receptor bispecifics in cancer and autoimmune disease into clinical trials.
Software P Pharmaceutical Commerce
Generative AI has made pharma teams faster, but real value depends on redesigning commercialization workflows, especially as agentic AI raises the governance stakes.
Industry
EMA Press
CVMP opinions on veterinary medicinal products Further to the re-examination of the opinion adopted by the Committee during its June 2026 meeting, the Committee adopted a…
Industry
BioPharma Dive
The deal is part of a course change for Hims, which had previously sold knockoff GLP-1 drugs. Elsewhere, a medicine Servier recently acquired failed a key trial and Ultragenyx announced staff cuts.
Industry P pharmaphorum
Lilly partners with Hims & Hers on obesity drug sales Phil.Taylor Fri, 06/11/2026 - 13:09
Software S Science News
Approach could provide scientists with a quicker, gentler way to gauge the health of bird populations
Funding P pharmaphorum
Inflammation-focused Rezera sets terms for IPO Phil.Taylor Fri, 06/11/2026 - 12:26
Industry
BioPharma Dive
The latest installment in BioPharma Dive’s visualization-focused series features a look at investors’ response to a trio of medicines highlighted in quarterly earnings this week.
Regulatory A Applied Clinical Trials
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how FDA inspection findings at APAC sites compare with those in the US and Europe, and why the common issues, such as informed consent versioning, are not unique to th…
Industry S Science News
Representative Zoe Lofgren prepares to lead the House science committee that microbiologist Jasmine Clark hopes to serve on
Regulatory
Pharmaceutical Technology
The accelerated approval marks the first indication beyond lung cancer for J&J’s bispecific antibody.
Clinical
Clinical Trials Arena
This positive result for Gilead's Livdelzi comes as recent clinical guidance recognises ALP normalisation as a key goal of treatment in PBC. The post Gilead seeks wider use for Livdelzi on Phase III liver disease success appeared first on Clinical Trials Arena.
Industry P pharmaphorum
Moderna, Oxford Uni Ebola jabs backed for pivotal testing Phil.Taylor Fri, 06/11/2026 - 11:14
Regulatory
Pharmaceutical Technology
Through its PPIE initiative, the MHRA plans to consider a diverse range of patient and public opinions when making regulatory decisions.
Industry A Applied Clinical Trials
In today’s ACT Brief, we examine why outdated views of Asia Pacific trial sites persist, how community access gaps reflect both patient costs and site infrastructure, and how VeonGen has aligned with the FDA on a pivotal gene therapy trial design.
Industry P Pharmaceutical Executive
When tumors shift, old treatments stop working. Dr. Brian Corgiat explains why real-time tumor profiling is critical to effective therapy.
Research A Applied Clinical Trials
Risk-based quality management depends on knowing what to monitor and on interpreting what the signals mean.
Research
Clinical Trials Arena
Amgen has reported that its human monoclonal antibody Repatha lowered fatal or non-fatal heart attack risk by 20% in a real-world trial over ezetimibe in patients with ASCVD. The post Amgen’s Repatha reduces heart attack risk in real-world study appeared first on Clinical Trials…
Industry
Pharmaceutical Technology
Armada Acquisition has entered a definitive business combination agreement with Brains Bioceutical that values the latter at an implied pre-money equity value of $750m.
Industry
European Biotechnology
Nine reports of tumors in children treated with Novartis' spinal muscular atrophy (SMA) gene therapy Zolgensma raise new questions about its long-term safety. In two cases, viral vector DNA was detected in the patients' genomes. In 2022, two children had already died of acute liv…
Industry P pharmaphorum
UK pilots shorter NICE appraisal for new medicines Phil.Taylor Fri, 06/11/2026 - 10:23
Clinical
Clinical Trials Arena
Mondego Bio has started a first-in-human Phase Ia clinical trial of MB 388, which is designed to act in both tumour cells and immune cells to overcome resistance to cancer immunotherapy. The post Mondego Bio begins Phase Ia trial of oral MB‑388 appeared first on Clinical Trials A…
Regulatory
Pharmaceutical Technology
Alfasigma has received the EC's expanded approval for Jyseleca to treat adult patients living with active axial spondyloarthritis (axSpA).
Regulatory P pharmaphorum
J&J's Rybrevant Faspro moves beyond lung cancer with FDA nod Phil.Taylor Fri, 06/11/2026 - 09:41
Research B BioTechniques
Original story from McGill University (Montreal, Canada). Scientists have discovered a surprising ability in immune cells that could reshape our understanding of how the body develops lasting protection against infections. A McGill University-led (Montreal, Canada) study has unco…
Funding P pharmaphorum
Kidney care raises its ambitions at ASN Kidney Week 2026 Nicole.Raleigh Fri, 06/11/2026 - 09:30
Industry
European Biotechnology
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us about the companies they join. This week: neuroscience experience for Oculis, an experienced CMO for ARTHEx and manufacturing leadership for CRISPR Therapeut…
Industry
Labiotech
Joining us is Shashi Koduru, Senior Director of Business Development at Vector BioMed. We discuss how he finds the right partners, and makes short meetings productive. The post How to turn a BIO-Europe meeting into a lasting partnership appeared first on Labiotech.eu. © Labiotech…